HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Jennifer Young Joins icometrix As CEO
Jennifer Young brings over 20 years of experience in the radiology, medical device, and healthcare services business spanning the provider, employer and payer markets.
Nordson Corporation Names Joseph P Kelley as Chief Financial Officer
Joseph P Kelley brings over 25 years of financial and operational expertise to the role. Since 2015, he has served as CFO of Materion, a $1.2 billion advanced materials company.
Drew Mellan New Director of Account Management of Noble
In this new position, Drew Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.
Dr Peter Meintjes joins Transplant Genomics as CCO
Dr Peter Meintjes joins TGI after six years at Omixon, a world leader in pre-transplant HLA Typing, where he departs as CEO, having grown the company at a CAGR of >75% since its first full year of operation as a molecular diagnostics company.
Orchestra BioMed Enhances Management Team with Appointment of Regulatory Affairs and Combination Product Expert Bob Laughner as Vice President, Regulatory Affairs
Bob Laughner will play a lead role in advancing Orchestra BioMed’s Virtue® Sirolimus AngioInfusion™ Balloon (SAB) through global regulatory approvals.
Dr Efthymios Deliargyris Appointed New CMO of Cytosorbents
Dr Efthymios Deliargyris brings over 19 years of experience in both academic medicine and industry to the position of Chief Medical Officer.
John Murphy PhD Appointed GTX Medical BV Chief Technology Officer
John Murphy PhD joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization.
Dan Myers Appointed CEO of Leo Lens Pharma
Prior to joining Leo Lens Pharma, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors.
CHPA Welcomes Procter & Gamble’s Paul Gama as Board Chair
Gama is President of Personal Health Care (PHC) for The Procter & Gamble Company (P&G), leading their global healthcare portfolio of OTC medicines, dietary supplements, and consumer medical devices.
